Applied Clinical Trials Trends

In this ISSUE

Measuring Adoption and Value of Patient Engagement

Rare Diseases Don't Feel So Rare to Me

Developing New Clinical Endpoints for Immuno-Oncology Studies

Technology Innovation

The Clinical Trial of Tomorrow

Highlighting the six broad technology themes poised to transform future R&D.
... /Read more/

Interested in knowing the benefits of a unified clinical operating model? Complete this industry survey and we'll share the results with you.
Take the

Veeva 2017 Unified Clinical Operations Survey

Clinical Insight

How is Endpoint Adjudication Impacting Clinical Operations?

This survey on Endpoint Adjudication evaluates how this concept is impacting study design, uncovering operational challenges and determining outcomes.
... /Read more/

Improving Clinical Trial Transparency, Collaboration and Efficiencies
Live Webinar: Wednesday, March 29 at 11:00am EDT

Calendar

/ ADF 2017 - Abuse-Deterrent Formulations Summit 3/7-3/8 /

Alexandria, Virginia

/ Expanded Access Programs 3/9-3/10 /

Alexandria, Virginia

/ Risk-Based Monitoring Europe 3/15-3/16 /

Barcelona, Spain

Risk-Based Monitoring

Advancements in RBM and Quantitative Metrics

Justin Stark, Head and Director of Risk-based Monitoring and Standards are UCB discusses advancements in RBM and TransCelerate’s Quantitative Metrics Toolkit.
... /Read more/

Use Challenge Trials Effectively in Clinical Studies: Lessons Learned from H3N2 Influenza Virus
Live Webinar: Tuesday, March 28 at 3 pm CEST and Thursday, April 6 at 10 am EDT

Good Clinical Practices

Drug Developers Embrace the Rising Prominence - and Influence - of Patient Advocacy

Patient advocates are witnessing a shift in the culture of drug development as sponsors and regulatory agencies show more interest in incorporating patient perspectives.
... /Read more/

Clinical Operations

Where’s the Exit? An Update on Brexit

With the U.K. poised to begin the process of leaving the European Union soon, many questions remain as to the specifics of pharma regulation and the wide-ranging effects of this departure.
... /Read more/

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Are Local IRBs Really Necessary?
On Demand

Learn more

Advertise

Mike Tessalone
Publisher
Michael.Tessalone@ubm.com

website / blog / advertise / subscribe